Self Heal Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 23-10-2024
- Revenue 13.07%
(FY 2023)
- Profit 76.47%
(FY 2023)
- Ebitda 36.47%
(FY 2023)
- Net Worth 10.45%
(FY 2023)
- Total Assets 22.43%
(FY 2023)
About Self Heal Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Varadan Cetlur and Ashok Singh serve as directors at the Company.
- CIN/LLPIN
U74140MH2014PTC252378
- Company No.
252378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Self Heal Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Singh  | Managing Director | 16-May-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varadan Cetlur | Director | 16-May-2019 | Current |
Financial Performance of Self Heal Lifesciences.
Self Heal Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.07% increase. The company also saw a substantial improvement in profitability, with a 76.47% increase in profit. The company's net worth Soared by an impressive increase of 10.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Self Heal Lifesciences?
In 2023, Self Heal Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iris Super Speciality Polyclinic Private LimitedActive 4 years 9 monthsVaradan Cetlur and Ashok Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 27 Sep 2023 | ₹1.00 Cr | Open |
Indian Bank Creation Date: 21 Jan 2022 | ₹5.00 M | Open |
How Many Employees Work at Self Heal Lifesciences?
Unlock and access historical data on people associated with Self Heal Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Self Heal Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Self Heal Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
